APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Diuretic Drugs

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Diuretic Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Report ID 173985270330 December 2025198 pages

Choose your research edition.

Industry ResearchDiuretic Drugs Industry Research Report 2026139 pages · $2,950 USDIndustry Growth & TrendsGlobal Diuretic Drugs Industry Growth and Trends Forecast to 2032114 pages · $3,450 USDMarket StructureGlobal Diuretic Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Diuretic Drugs Market Outlook and Growth Opportunities 2026200 pages · $4,250 USDMarket Analysis & ForecastGlobal Diuretic Drugs Market Analysis and Forecast 2026-2032200 pages · $4,950 USD

Market perspective

The global Diuretic Drugs market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Diuretic Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Diuretic Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Diuretic Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Diuretic Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Diuretic Drugs include Aurobindo Pharma, Bristol-Myers Squibb Compan, F.Hoffmann-La Roche, Fresenius Kabi, Glaxosmithkline, GSK plc, Hikma Pharmaceuticals PLC, Meda Pharmaceuticals and Novartis Pharmaceuticals, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Diuretic Drugs market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Diuretic Drugs and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Diuretic Drugs sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Diuretic Drugs market size, projected growth trends, production technologies, key applications, and end-use industries.

Diuretic Drugs Segment by Company

Aurobindo Pharma

Bristol-Myers Squibb Compan

F.Hoffmann-La Roche

Fresenius Kabi

Glaxosmithkline

GSK plc

Hikma Pharmaceuticals PLC

Meda Pharmaceuticals

Novartis Pharmaceuticals

Teva Pharmaceutical lndustries

yCipla

AstraZeneca

Bayer

Pfizer

Roche

Mylan

Sanofi

Diuretic Drugs Segment by Type

Potassium-sparing Diuretics

Loop Diuretics

Thiazide Diuretics

Osmotic Diuretics

Carbonic Anhydrase Inhibitors

Diuretic Drugs Segment by Application

Online Pharmacies

Hospital Pharmacies

Retail Pharmacies

Diuretic Drugs Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Diuretic Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Diuretic Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Diuretic Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Diuretic Drugs market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Diuretic Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Diuretic Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Diuretic Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Diuretic Drugs Industry Trends Table 2. Diuretic Drugs Industry Drivers Table 3. Diuretic Drugs Industry Opportunities and Challenges Table 4. Diuretic Drugs Industry Restraints Table 5. Global Diuretic Drugs Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Diuretic Drugs Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Diuretic Drugs Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Diuretic Drugs Sales Market Share by Manufacturers Table 9. Global Diuretic Drugs Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Diuretic Drugs Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Diuretic Drugs Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Diuretic Drugs Manufacturers, Product Type & Application Table 13. Global Diuretic Drugs Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Diuretic Drugs by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Potassium-sparing Diuretics Table 17. Major Manufacturers of Loop Diuretics Table 18. Major Manufacturers of Thiazide Diuretics Table 19. Major Manufacturers of Osmotic Diuretics Table 20. Major Manufacturers of Carbonic Anhydrase Inhibitors Table 21. Global Diuretic Drugs Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 22. Global Diuretic Drugs Sales by Type (2021-2026) & (K Units) Table 23. Global Diuretic Drugs Sales by Type (2027-2032) & (K Units) Table 24. Global Diuretic Drugs Sales Market Share by Type (2021-2026) Table 25. Global Diuretic Drugs Sales Market Share by Type (2027-2032) Table 26. Global Diuretic Drugs Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 27. Global Diuretic Drugs Revenue by Type (2021-2026) & (K Units) Table 28. Global Diuretic Drugs Revenue by Type (2027-2032) & (K Units) Table 29. Global Diuretic Drugs Revenue Market Share by Type (2021-2026) Table 30. Global Diuretic Drugs Revenue Market Share by Type (2027-2032) Table 31. Major Manufacturers of Online Pharmacies Table 32. Major Manufacturers of Hospital Pharmacies Table 33. Major Manufacturers of Retail Pharmacies Table 34. Global Diuretic Drugs Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 35. Global Diuretic Drugs Sales by Application (2021-2026) & (K Units) Table 36. Global Diuretic Drugs Sales by Application (2027-2032) & (K Units) Table 37. Global Diuretic Drugs Sales Market Share by Application (2021-2026) Table 38. Global Diuretic Drugs Sales Market Share by Application (2027-2032) Table 39. Global Diuretic Drugs Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 40. Global Diuretic Drugs Revenue by Application (2021-2026) & (K Units) Table 41. Global Diuretic Drugs Revenue by Application (2027-2032) & (K Units) Table 42. Global Diuretic Drugs Revenue Market Share by Application (2021-2026) Table 43. Global Diuretic Drugs Revenue Market Share by Application (2027-2032) Table 44. Global Diuretic Drugs Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 45. Global Diuretic Drugs Sales by Region (2021-2026) & (K Units) Table 46. Global Diuretic Drugs Sales Market Share by Region (2021-2026) Table 47. Global Diuretic Drugs Sales Forecasted by Region (2027-2032) & (K Units) Table 48. Global Diuretic Drugs Sales Forecasted Market Share by Region (2027-2032) Table 49. North America Diuretic Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 50. North America Diuretic Drugs Sales by Country (2021-2026) & (K Units) Table 51. North America Diuretic Drugs Sales by Country (2027-2032) & (K Units) Table 52. Europe Diuretic Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 53. Europe Diuretic Drugs Sales by Country (2021-2026) & (K Units) Table 54. Europe Diuretic Drugs Sales by Country (2027-2032) & (K Units) Table 55. Asia Pacific Diuretic Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 56. Asia Pacific Diuretic Drugs Sales by Country (2021-2026) & (K Units) Table 57. Asia Pacific Diuretic Drugs Sales by Country (2027-2032) & (K Units) Table 58. South America, Middle East and Africa Diuretic Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 59. South America, Middle East and Africa Diuretic Drugs Sales by Country (2021-2026) & (K Units) Table 60. South America, Middle East and Africa Diuretic Drugs Sales by Country (2027-2032) & (K Units) Table 61. Global Diuretic Drugs Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 62. Global Diuretic Drugs Revenue by Region (2021-2026) & (US$ Million) Table 63. Global Diuretic Drugs Revenue by Region (2027-2032) & (US$ Million) Table 64. Global Diuretic Drugs Revenue Market Share by Region (2021-2026) Table 65. Global Diuretic Drugs Revenue Market Share by Region (2027-2032) Table 66. Aurobindo Pharma Company Information Table 67. Aurobindo Pharma Business Overview Table 68. Aurobindo Pharma Diuretic Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 69. Aurobindo Pharma Diuretic Drugs Product Portfolio Table 70. Aurobindo Pharma Recent Development Table 71. Bristol-Myers Squibb Compan Company Information Table 72. Bristol-Myers Squibb Compan Business Overview Table 73. Bristol-Myers Squibb Compan Diuretic Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 74. Bristol-Myers Squibb Compan Diuretic Drugs Product Portfolio Table 75. Bristol-Myers Squibb Compan Recent Development Table 76. F.Hoffmann-La Roche Company Information Table 77. F.Hoffmann-La Roche Business Overview Table 78. F.Hoffmann-La Roche Diuretic Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 79. F.Hoffmann-La Roche Diuretic Drugs Product Portfolio Table 80. F.Hoffmann-La Roche Recent Development Table 81. Fresenius Kabi Company Information Table 82. Fresenius Kabi Business Overview Table 83. Fresenius Kabi Diuretic Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 84. Fresenius Kabi Diuretic Drugs Product Portfolio Table 85. Fresenius Kabi Recent Development Table 86. Glaxosmithkline Company Information Table 87. Glaxosmithkline Business Overview Table 88. Glaxosmithkline Diuretic Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 89. Glaxosmithkline Diuretic Drugs Product Portfolio Table 90. Glaxosmithkline Recent Development Table 91. GSK plc Company Information Table 92. GSK plc Business Overview Table 93. GSK plc Diuretic Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 94. GSK plc Diuretic Drugs Product Portfolio Table 95. GSK plc Recent Development Table 96. Hikma Pharmaceuticals PLC Company Information Table 97. Hikma Pharmaceuticals PLC Business Overview Table 98. Hikma Pharmaceuticals PLC Diuretic Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 99. Hikma Pharmaceuticals PLC Diuretic Drugs Product Portfolio Table 100. Hikma Pharmaceuticals PLC Recent Development Table 101. Meda Pharmaceuticals Company Information Table 102. Meda Pharmaceuticals Business Overview Table 103. Meda Pharmaceuticals Diuretic Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 104. Meda Pharmaceuticals Diuretic Drugs Product Portfolio Table 105. Meda Pharmaceuticals Recent Development Table 106. Novartis Pharmaceuticals Company Information Table 107. Novartis Pharmaceuticals Business Overview Table 108. Novartis Pharmaceuticals Diuretic Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 109. Novartis Pharmaceuticals Diuretic Drugs Product Portfolio Table 110. Novartis Pharmaceuticals Recent Development Table 111. Teva Pharmaceutical lndustries Company Information Table 112. Teva Pharmaceutical lndustries Business Overview Table 113. Teva Pharmaceutical lndustries Diuretic Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 114. Teva Pharmaceutical lndustries Diuretic Drugs Product Portfolio Table 115. Teva Pharmaceutical lndustries Recent Development Table 116. yCipla Company Information Table 117. yCipla Business Overview Table 118. yCipla Diuretic Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 119. yCipla Diuretic Drugs Product Portfolio Table 120. yCipla Recent Development Table 121. AstraZeneca Company Information Table 122. AstraZeneca Business Overview Table 123. AstraZeneca Diuretic Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 124. AstraZeneca Diuretic Drugs Product Portfolio Table 125. AstraZeneca Recent Development Table 126. Bayer Company Information Table 127. Bayer Business Overview Table 128. Bayer Diuretic Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 129. Bayer Diuretic Drugs Product Portfolio Table 130. Bayer Recent Development Table 131. Pfizer Company Information Table 132. Pfizer Business Overview Table 133. Pfizer Diuretic Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 134. Pfizer Diuretic Drugs Product Portfolio Table 135. Pfizer Recent Development Table 136. Roche Company Information Table 137. Roche Business Overview Table 138. Roche Diuretic Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 139. Roche Diuretic Drugs Product Portfolio Table 140. Roche Recent Development Table 141. Mylan Company Information Table 142. Mylan Business Overview Table 143. Mylan Diuretic Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 144. Mylan Diuretic Drugs Product Portfolio Table 145. Mylan Recent Development Table 146. Sanofi Company Information Table 147. Sanofi Business Overview Table 148. Sanofi Diuretic Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 149. Sanofi Diuretic Drugs Product Portfolio Table 150. Sanofi Recent Development Table 151. Key Raw Materials Table 152. Raw Materials Key Suppliers Table 153. Diuretic Drugs Distributors List Table 154. Diuretic Drugs Customers List Table 155. Research Programs/Design for This Report Table 156. Authors List of This Report Table 157. Secondary Sources Table 158. Primary Sources List of Figures Figure 1. Diuretic Drugs Product Image Figure 2. Global Diuretic Drugs Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Diuretic Drugs Market Size (2021-2032) & (US$ Million) Figure 4. Global Diuretic Drugs Sales (2021-2032) & (K Units) Figure 5. Global Diuretic Drugs Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Diuretic Drugs Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Potassium-sparing Diuretics Image Figure 9. Loop Diuretics Image Figure 10. Thiazide Diuretics Image Figure 11. Osmotic Diuretics Image Figure 12. Carbonic Anhydrase Inhibitors Image Figure 13. Global Diuretic Drugs Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 14. Global Diuretic Drugs Sales Market Share 2021 VS 2025 VS 2032 Figure 15. Global Diuretic Drugs Sales Market Share by Type (2021-2032) Figure 16. Global Diuretic Drugs Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 17. Global Diuretic Drugs Revenue Market Share 2021 VS 2025 VS 2032 Figure 18. Global Diuretic Drugs Revenue Market Share by Type (2021-2032) Figure 19. Online Pharmacies Image Figure 20. Hospital Pharmacies Image Figure 21. Retail Pharmacies Image Figure 22. Global Diuretic Drugs Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 23. Global Diuretic Drugs Sales Market Share 2021 VS 2025 VS 2032 Figure 24. Global Diuretic Drugs Sales Market Share by Application (2021-2032) Figure 25. Global Diuretic Drugs Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 26. Global Diuretic Drugs Revenue Market Share 2021 VS 2025 VS 2032 Figure 27. Global Diuretic Drugs Revenue Market Share by Application (2021-2032) Figure 28. North America Diuretic Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 29. North America Diuretic Drugs Sales Market Share by Country (2021-2032) Figure 30. U.S. Diuretic Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Canada Diuretic Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 32. Mexico Diuretic Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 33. Europe Diuretic Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 34. Europe Diuretic Drugs Sales Market Share by Country (2021-2032) Figure 35. Germany Diuretic Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 36. France Diuretic Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 37. U.K. Diuretic Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Italy Diuretic Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 39. Netherlands Diuretic Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 40. Asia Pacific Diuretic Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 41. Asia Pacific Diuretic Drugs Sales Market Share by Country (2021-2032) Figure 42. China Diuretic Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 43. Japan Diuretic Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 44. South Korea Diuretic Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 45. Southeast Asia Diuretic Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 46. India Diuretic Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 47. Australia Diuretic Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 48. South America, Middle East and Africa Diuretic Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 49. South America, Middle East and Africa Diuretic Drugs Sales Market Share by Country (2021-2032) Figure 50. Brazil Diuretic Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 51. South Africa Diuretic Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 52. Saudi Arabia Diuretic Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Turkey Diuretic Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Argentina Diuretic Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 55. UAE Diuretic Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 56. Egypt Diuretic Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 57. Chile Diuretic Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 58. Global Diuretic Drugs Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 59. Global Diuretic Drugs Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 60. North America Diuretic Drugs Revenue (2021-2032) & (US$ Million) Figure 61. North America Diuretic Drugs Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. Europe Diuretic Drugs Revenue (2021-2032) & (US$ Million) Figure 63. Europe Diuretic Drugs Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. Asia-Pacific Diuretic Drugs Revenue (2021-2032) & (US$ Million) Figure 65. Asia-Pacific Diuretic Drugs Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. South America, Middle East and Africa Diuretic Drugs Revenue (2021-2032) & (US$ Million) Figure 67. South America, Middle East and Africa Diuretic Drugs Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 68. Diuretic Drugs Value Chain Figure 69. Manufacturing Cost Structure Figure 70. Diuretic Drugs Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Potassium-sparing Diuretics
  • Loop Diuretics
  • Thiazide Diuretics
  • Osmotic Diuretics
  • Carbonic Anhydrase Inhibitors
Applications
  • Online Pharmacies
  • Hospital Pharmacies
  • Retail Pharmacies
Companies covered
  • Aurobindo Pharma
  • Bristol-Myers Squibb Compan
  • F.Hoffmann-La Roche
  • Fresenius Kabi
  • Glaxosmithkline
  • GSK plc
  • Hikma Pharmaceuticals PLC
  • Meda Pharmaceuticals
  • Novartis Pharmaceuticals
  • Teva Pharmaceutical lndustries
  • yCipla
  • AstraZeneca
  • Bayer
  • Pfizer
  • Roche
  • Mylan
  • Sanofi

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Diuretic Drugs Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Diuretic Drugs Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Diuretic Drugs Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Diuretic Drugs Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Diuretic Drugs Market Dynamics
  1. 2.1 Diuretic Drugs Industry Trends
  2. 2.2 Diuretic Drugs Industry Drivers
  3. 2.3 Diuretic Drugs Industry Opportunities and Challenges
  4. 2.4 Diuretic Drugs Industry Restraints
3 Diuretic Drugs Market by Manufacturers
  1. 3.1 Global Diuretic Drugs Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Diuretic Drugs Sales by Manufacturers (2021-2026)
  3. 3.3 Global Diuretic Drugs Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Diuretic Drugs Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Diuretic Drugs Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Diuretic Drugs Manufacturers, Product Type & Application
  7. 3.7 Global Diuretic Drugs Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Diuretic Drugs Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Diuretic Drugs Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Diuretic Drugs Tier 1, Tier 2, and Tier 3
4 Diuretic Drugs Market by Type
  1. 4.1 Diuretic Drugs Type Introduction
  2. 4.1.1 Potassium-sparing Diuretics
  3. 4.1.2 Loop Diuretics
  4. 4.1.3 Thiazide Diuretics
  5. 4.1.4 Osmotic Diuretics
  6. 4.1.5 Carbonic Anhydrase Inhibitors
  7. 4.2 Global Diuretic Drugs Sales by Type
  8. 4.2.1 Global Diuretic Drugs Sales by Type (2021 VS 2025 VS 2032)
  9. 4.2.2 Global Diuretic Drugs Sales by Type (2021-2032)
  10. 4.2.3 Global Diuretic Drugs Sales Market Share by Type (2021-2032)
  11. 4.3 Global Diuretic Drugs Revenue by Type
  12. 4.3.1 Global Diuretic Drugs Revenue by Type (2021 VS 2025 VS 2032)
  13. 4.3.2 Global Diuretic Drugs Revenue by Type (2021-2032)
  14. 4.3.3 Global Diuretic Drugs Revenue Market Share by Type (2021-2032)
5 Diuretic Drugs Market by Application
  1. 5.1 Diuretic Drugs Application Introduction
  2. 5.1.1 Online Pharmacies
  3. 5.1.2 Hospital Pharmacies
  4. 5.1.3 Retail Pharmacies
  5. 5.2 Global Diuretic Drugs Sales by Application
  6. 5.2.1 Global Diuretic Drugs Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Diuretic Drugs Sales by Application (2021-2032)
  8. 5.2.3 Global Diuretic Drugs Sales Market Share by Application (2021-2032)
  9. 5.3 Global Diuretic Drugs Revenue by Application
  10. 5.3.1 Global Diuretic Drugs Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Diuretic Drugs Revenue by Application (2021-2032)
  12. 5.3.3 Global Diuretic Drugs Revenue Market Share by Application (2021-2032)
6 Global Diuretic Drugs Sales by Region
  1. 6.1 Global Diuretic Drugs Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Diuretic Drugs Sales by Region (2021-2032)
  3. 6.2.1 Global Diuretic Drugs Sales by Region (2021-2026)
  4. 6.2.2 Global Diuretic Drugs Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Diuretic Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Diuretic Drugs Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Diuretic Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Diuretic Drugs Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Diuretic Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Diuretic Drugs Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Diuretic Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Diuretic Drugs Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Diuretic Drugs Revenue by Region
  1. 7.1 Global Diuretic Drugs Revenue by Region
  2. 7.1.1 Global Diuretic Drugs Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Diuretic Drugs Revenue by Region (2021-2026)
  4. 7.1.3 Global Diuretic Drugs Revenue by Region (2027-2032)
  5. 7.1.4 Global Diuretic Drugs Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Diuretic Drugs Revenue (2021-2032)
  8. 7.2.2 North America Diuretic Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Diuretic Drugs Revenue (2021-2032)
  11. 7.3.2 Europe Diuretic Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Diuretic Drugs Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Diuretic Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Diuretic Drugs Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Diuretic Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Aurobindo Pharma
  2. 8.1.1 Aurobindo Pharma Company Information
  3. 8.1.2 Aurobindo Pharma Business Overview
  4. 8.1.3 Aurobindo Pharma Diuretic Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Aurobindo Pharma Diuretic Drugs Product Portfolio
  6. 8.1.5 Aurobindo Pharma Recent Developments
  7. 8.2 Bristol-Myers Squibb Compan
  8. 8.2.1 Bristol-Myers Squibb Compan Company Information
  9. 8.2.2 Bristol-Myers Squibb Compan Business Overview
  10. 8.2.3 Bristol-Myers Squibb Compan Diuretic Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Bristol-Myers Squibb Compan Diuretic Drugs Product Portfolio
  12. 8.2.5 Bristol-Myers Squibb Compan Recent Developments
  13. 8.3 F.Hoffmann-La Roche
  14. 8.3.1 F.Hoffmann-La Roche Company Information
  15. 8.3.2 F.Hoffmann-La Roche Business Overview
  16. 8.3.3 F.Hoffmann-La Roche Diuretic Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 F.Hoffmann-La Roche Diuretic Drugs Product Portfolio
  18. 8.3.5 F.Hoffmann-La Roche Recent Developments
  19. 8.4 Fresenius Kabi
  20. 8.4.1 Fresenius Kabi Company Information
  21. 8.4.2 Fresenius Kabi Business Overview
  22. 8.4.3 Fresenius Kabi Diuretic Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Fresenius Kabi Diuretic Drugs Product Portfolio
  24. 8.4.5 Fresenius Kabi Recent Developments
  25. 8.5 Glaxosmithkline
  26. 8.5.1 Glaxosmithkline Company Information
  27. 8.5.2 Glaxosmithkline Business Overview
  28. 8.5.3 Glaxosmithkline Diuretic Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Glaxosmithkline Diuretic Drugs Product Portfolio
  30. 8.5.5 Glaxosmithkline Recent Developments
  31. 8.6 GSK plc
  32. 8.6.1 GSK plc Company Information
  33. 8.6.2 GSK plc Business Overview
  34. 8.6.3 GSK plc Diuretic Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 GSK plc Diuretic Drugs Product Portfolio
  36. 8.6.5 GSK plc Recent Developments
  37. 8.7 Hikma Pharmaceuticals PLC
  38. 8.7.1 Hikma Pharmaceuticals PLC Company Information
  39. 8.7.2 Hikma Pharmaceuticals PLC Business Overview
  40. 8.7.3 Hikma Pharmaceuticals PLC Diuretic Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Hikma Pharmaceuticals PLC Diuretic Drugs Product Portfolio
  42. 8.7.5 Hikma Pharmaceuticals PLC Recent Developments
  43. 8.8 Meda Pharmaceuticals
  44. 8.8.1 Meda Pharmaceuticals Company Information
  45. 8.8.2 Meda Pharmaceuticals Business Overview
  46. 8.8.3 Meda Pharmaceuticals Diuretic Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Meda Pharmaceuticals Diuretic Drugs Product Portfolio
  48. 8.8.5 Meda Pharmaceuticals Recent Developments
  49. 8.9 Novartis Pharmaceuticals
  50. 8.9.1 Novartis Pharmaceuticals Company Information
  51. 8.9.2 Novartis Pharmaceuticals Business Overview
  52. 8.9.3 Novartis Pharmaceuticals Diuretic Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Novartis Pharmaceuticals Diuretic Drugs Product Portfolio
  54. 8.9.5 Novartis Pharmaceuticals Recent Developments
  55. 8.10 Teva Pharmaceutical lndustries
  56. 8.10.1 Teva Pharmaceutical lndustries Company Information
  57. 8.10.2 Teva Pharmaceutical lndustries Business Overview
  58. 8.10.3 Teva Pharmaceutical lndustries Diuretic Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Teva Pharmaceutical lndustries Diuretic Drugs Product Portfolio
  60. 8.10.5 Teva Pharmaceutical lndustries Recent Developments
  61. 8.11 yCipla
  62. 8.11.1 yCipla Company Information
  63. 8.11.2 yCipla Business Overview
  64. 8.11.3 yCipla Diuretic Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 yCipla Diuretic Drugs Product Portfolio
  66. 8.11.5 yCipla Recent Developments
  67. 8.12 AstraZeneca
  68. 8.12.1 AstraZeneca Company Information
  69. 8.12.2 AstraZeneca Business Overview
  70. 8.12.3 AstraZeneca Diuretic Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 AstraZeneca Diuretic Drugs Product Portfolio
  72. 8.12.5 AstraZeneca Recent Developments
  73. 8.13 Bayer
  74. 8.13.1 Bayer Company Information
  75. 8.13.2 Bayer Business Overview
  76. 8.13.3 Bayer Diuretic Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Bayer Diuretic Drugs Product Portfolio
  78. 8.13.5 Bayer Recent Developments
  79. 8.14 Pfizer
  80. 8.14.1 Pfizer Company Information
  81. 8.14.2 Pfizer Business Overview
  82. 8.14.3 Pfizer Diuretic Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Pfizer Diuretic Drugs Product Portfolio
  84. 8.14.5 Pfizer Recent Developments
  85. 8.15 Roche
  86. 8.15.1 Roche Company Information
  87. 8.15.2 Roche Business Overview
  88. 8.15.3 Roche Diuretic Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Roche Diuretic Drugs Product Portfolio
  90. 8.15.5 Roche Recent Developments
  91. 8.16 Mylan
  92. 8.16.1 Mylan Company Information
  93. 8.16.2 Mylan Business Overview
  94. 8.16.3 Mylan Diuretic Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Mylan Diuretic Drugs Product Portfolio
  96. 8.16.5 Mylan Recent Developments
  97. 8.17 Sanofi
  98. 8.17.1 Sanofi Company Information
  99. 8.17.2 Sanofi Business Overview
  100. 8.17.3 Sanofi Diuretic Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Sanofi Diuretic Drugs Product Portfolio
  102. 8.17.5 Sanofi Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Diuretic Drugs Value Chain Analysis
  2. 9.1.1 Diuretic Drugs Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Diuretic Drugs Production Mode & Process
  6. 9.2 Diuretic Drugs Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Diuretic Drugs Distributors
  9. 9.2.3 Diuretic Drugs Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst